Perrigo, Actavis, others file reply against claim splitting in US states' generic drug antitrust case
MLex Summary: Perrigo, Actavis, Amneal and other pharmaceutical companies filed a reply in support of a judgment against splitting claims in US states’ case over generic drug pricing. They said that...To view the full article, register now.
Already a subscriber? Click here to view full article